Guam vs Uzbekistan: Incidence of tuberculosis
Incidence of tuberculosis over time
- Guam
- Uzbekistan
How they compare
Guam currently reports 55 per 100,000 people against 51 per 100,000 people in Uzbekistan, a difference of 4 per 100,000 people.
That makes Guam's figure about 1.1 times Uzbekistan's.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Uzbekistan ahead.
Guam ranks 87th and Uzbekistan ranks 89th of 208 countries.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guam | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.6 per 100,000 people | 151.2 per 100,000 people | 75.6 per 100,000 people | Uzbekistan |
| 2010s | 73.4 per 100,000 people | 81.2 per 100,000 people | 7.8 per 100,000 people | Uzbekistan |
| 2020s | 52.2 per 100,000 people | 57 per 100,000 people | 4.8 per 100,000 people | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Guam or Uzbekistan?
- Guam, at 55 per 100,000 people against 51 per 100,000 people in Uzbekistan as of 2024.
- What is the difference in incidence of tuberculosis between Guam and Uzbekistan?
- 4 per 100,000 people, with Guam ahead.
- How many years of comparable data are there for Guam and Uzbekistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Guam and Uzbekistan rank globally for incidence of tuberculosis?
- Guam ranks 87th and Uzbekistan ranks 89th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.